The First experience of robot assisted spleen-preserving laparoscopic distal pancreatectomy in Korea

Dong Hyun Kim, ChangMoo Kang, Woo Jung Lee, Hoon Sang Chi

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Spleen-preservation has recently been emphasized in benign and borderline malignant pancreatic diseases requiring distal pancreatectomy. Reports to suggest that laparoscopic distal pancreatectomy is feasible and safe have been increasingly published. Robotic surgical system has been introduced and is expected to provide unique advantages in laparoscopic surgery. However, robot-assisted pancreatic surgery has not yet been performed by many surgeons. A 45-year-old female patient with abdominal discomfort was found to have pancreatic cyst in the body of the pancreas. Mucinous cystic tumor of the pancreas was the most favourable preoperative diagnosis. She underwent spleen-preserving laparoscopic distal pancreatectomy by using da Vinci surgical robot system. Splenic artery and vein were so tightly adherent to the pancreatic cyst that segmental resection of splenic vessels was required. Postoperative course was uneventful. She was able to come home in 5 days after surgery. Postoperative follow up color doppler ultrasound scan, taken on 2 weeks after surgery, showed minimal fluid collection around surgical field and no evidence of splenic infarction with good preservation of splenic perfusion. Robot-assisted spleen preserving distal pancreatectomy is thought to be feasible and safe. Several unique advantages of robotic system are expected to enhance safer and more precise surgical performance in near future. More experiences are mandatory to confirm real benefit of robot surgery in pancreatic disease.

Original languageEnglish
Pages (from-to)539-542
Number of pages4
JournalYonsei medical journal
Volume52
Issue number3
DOIs
Publication statusPublished - 2011 May 1

Fingerprint

Pancreatectomy
Korea
Spleen
Pancreatic Cyst
Pancreatic Diseases
Robotics
Pancreas
Splenic Infarction
Splenic Vein
Splenic Artery
Doppler Ultrasonography
Ambulatory Surgical Procedures
Laparoscopy
Color
Perfusion
Neoplasms

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Kim, Dong Hyun ; Kang, ChangMoo ; Lee, Woo Jung ; Chi, Hoon Sang. / The First experience of robot assisted spleen-preserving laparoscopic distal pancreatectomy in Korea. In: Yonsei medical journal. 2011 ; Vol. 52, No. 3. pp. 539-542.
@article{f248d31ca3224ef2817a4a28650a6320,
title = "The First experience of robot assisted spleen-preserving laparoscopic distal pancreatectomy in Korea",
abstract = "Spleen-preservation has recently been emphasized in benign and borderline malignant pancreatic diseases requiring distal pancreatectomy. Reports to suggest that laparoscopic distal pancreatectomy is feasible and safe have been increasingly published. Robotic surgical system has been introduced and is expected to provide unique advantages in laparoscopic surgery. However, robot-assisted pancreatic surgery has not yet been performed by many surgeons. A 45-year-old female patient with abdominal discomfort was found to have pancreatic cyst in the body of the pancreas. Mucinous cystic tumor of the pancreas was the most favourable preoperative diagnosis. She underwent spleen-preserving laparoscopic distal pancreatectomy by using da Vinci surgical robot system. Splenic artery and vein were so tightly adherent to the pancreatic cyst that segmental resection of splenic vessels was required. Postoperative course was uneventful. She was able to come home in 5 days after surgery. Postoperative follow up color doppler ultrasound scan, taken on 2 weeks after surgery, showed minimal fluid collection around surgical field and no evidence of splenic infarction with good preservation of splenic perfusion. Robot-assisted spleen preserving distal pancreatectomy is thought to be feasible and safe. Several unique advantages of robotic system are expected to enhance safer and more precise surgical performance in near future. More experiences are mandatory to confirm real benefit of robot surgery in pancreatic disease.",
author = "Kim, {Dong Hyun} and ChangMoo Kang and Lee, {Woo Jung} and Chi, {Hoon Sang}",
year = "2011",
month = "5",
day = "1",
doi = "10.3349/ymj.2011.52.3.539",
language = "English",
volume = "52",
pages = "539--542",
journal = "Yonsei Medical Journal",
issn = "0513-5796",
publisher = "Yonsei University College of Medicine",
number = "3",

}

The First experience of robot assisted spleen-preserving laparoscopic distal pancreatectomy in Korea. / Kim, Dong Hyun; Kang, ChangMoo; Lee, Woo Jung; Chi, Hoon Sang.

In: Yonsei medical journal, Vol. 52, No. 3, 01.05.2011, p. 539-542.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The First experience of robot assisted spleen-preserving laparoscopic distal pancreatectomy in Korea

AU - Kim, Dong Hyun

AU - Kang, ChangMoo

AU - Lee, Woo Jung

AU - Chi, Hoon Sang

PY - 2011/5/1

Y1 - 2011/5/1

N2 - Spleen-preservation has recently been emphasized in benign and borderline malignant pancreatic diseases requiring distal pancreatectomy. Reports to suggest that laparoscopic distal pancreatectomy is feasible and safe have been increasingly published. Robotic surgical system has been introduced and is expected to provide unique advantages in laparoscopic surgery. However, robot-assisted pancreatic surgery has not yet been performed by many surgeons. A 45-year-old female patient with abdominal discomfort was found to have pancreatic cyst in the body of the pancreas. Mucinous cystic tumor of the pancreas was the most favourable preoperative diagnosis. She underwent spleen-preserving laparoscopic distal pancreatectomy by using da Vinci surgical robot system. Splenic artery and vein were so tightly adherent to the pancreatic cyst that segmental resection of splenic vessels was required. Postoperative course was uneventful. She was able to come home in 5 days after surgery. Postoperative follow up color doppler ultrasound scan, taken on 2 weeks after surgery, showed minimal fluid collection around surgical field and no evidence of splenic infarction with good preservation of splenic perfusion. Robot-assisted spleen preserving distal pancreatectomy is thought to be feasible and safe. Several unique advantages of robotic system are expected to enhance safer and more precise surgical performance in near future. More experiences are mandatory to confirm real benefit of robot surgery in pancreatic disease.

AB - Spleen-preservation has recently been emphasized in benign and borderline malignant pancreatic diseases requiring distal pancreatectomy. Reports to suggest that laparoscopic distal pancreatectomy is feasible and safe have been increasingly published. Robotic surgical system has been introduced and is expected to provide unique advantages in laparoscopic surgery. However, robot-assisted pancreatic surgery has not yet been performed by many surgeons. A 45-year-old female patient with abdominal discomfort was found to have pancreatic cyst in the body of the pancreas. Mucinous cystic tumor of the pancreas was the most favourable preoperative diagnosis. She underwent spleen-preserving laparoscopic distal pancreatectomy by using da Vinci surgical robot system. Splenic artery and vein were so tightly adherent to the pancreatic cyst that segmental resection of splenic vessels was required. Postoperative course was uneventful. She was able to come home in 5 days after surgery. Postoperative follow up color doppler ultrasound scan, taken on 2 weeks after surgery, showed minimal fluid collection around surgical field and no evidence of splenic infarction with good preservation of splenic perfusion. Robot-assisted spleen preserving distal pancreatectomy is thought to be feasible and safe. Several unique advantages of robotic system are expected to enhance safer and more precise surgical performance in near future. More experiences are mandatory to confirm real benefit of robot surgery in pancreatic disease.

UR - http://www.scopus.com/inward/record.url?scp=79955630706&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955630706&partnerID=8YFLogxK

U2 - 10.3349/ymj.2011.52.3.539

DO - 10.3349/ymj.2011.52.3.539

M3 - Article

VL - 52

SP - 539

EP - 542

JO - Yonsei Medical Journal

JF - Yonsei Medical Journal

SN - 0513-5796

IS - 3

ER -